🎁 Black Friday: up to 50% off of annual plans
Apex Biotechnology Corp. (TPE:1733)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.00
-0.70 (-2.44%)
Nov 20, 2026, 1:30 PM CST

Apex Biotechnology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8581,9451,8521,6772,2442,132
Revenue Growth
-5.22%5.00%10.48%-25.29%5.28%6.30%
Cost of Revenue
1,2661,4061,3311,1451,6671,560
Gross Profit
591.49538.74521.34531.12576.84571.51
Selling, General & Admin
249.61234.33231.31224.26234.83216.77
Research & Development
164.42149.37161.52163.33165.45153.29
Operating Expenses
400.99398.02392.88389.4400.28366.56
Operating Income
190.51140.73128.46141.72176.56204.95
Interest Expense
-3.33-3.39-3.64-4.39-5.4-12.53
Interest & Investment Income
7.527.414.343.21.152.01
Currency Exchange Gain (Loss)
27.7427.7417.618.9754.71-58.6
Other Non Operating Income (Expenses)
-27.462.442.133.20.3217.41
EBT Excluding Unusual Items
194.97174.92148.9162.7227.35153.23
Gain (Loss) on Sale of Investments
14.9814.984.23-3.96-2.8931.7
Asset Writedown
----17.78-24.89-
Pretax Income
209.95189.9153.13140.96199.58184.94
Income Tax Expense
23.8826.8625.0225.2518.12-17.35
Earnings From Continuing Operations
186.07163.04128.1115.71181.45202.29
Minority Interest in Earnings
-0.46-0.15-0.110.070.33-0.07
Net Income
185.61162.89128115.78181.79202.22
Net Income to Common
185.61162.89128115.78181.79202.22
Net Income Growth
22.67%27.26%10.55%-36.31%-10.11%113.33%
Shares Outstanding (Basic)
100100100100100100
Shares Outstanding (Diluted)
100101100100101106
Shares Change
-0.40%0.15%0.08%-0.34%-4.70%-6.53%
EPS (Basic)
1.861.631.281.161.822.03
EPS (Diluted)
1.851.621.271.151.811.93
EPS Growth
23.39%27.56%10.44%-36.46%-6.16%120.97%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
171.03144.86300.43208.48-9.97153.28
Free Cash Flow Per Share
1.711.442.992.08-0.101.45
Dividend Per Share
1.3001.3001.2001.1001.4001.300
Dividend Growth
8.33%8.33%9.09%-21.43%7.69%18.18%
Gross Margin
31.84%27.70%28.15%31.68%25.70%26.81%
Operating Margin
10.26%7.24%6.94%8.45%7.87%9.62%
Profit Margin
9.99%8.38%6.91%6.91%8.10%9.49%
Free Cash Flow Margin
9.21%7.45%16.22%12.44%-0.44%7.19%
EBITDA
237.76190.92182.03206.52260.08291.6
EBITDA Margin
12.80%9.82%9.83%12.32%11.59%13.68%
D&A For EBITDA
47.2650.253.5664.883.5286.65
EBIT
190.51140.73128.46141.72176.56204.95
EBIT Margin
10.26%7.24%6.94%8.45%7.87%9.62%
Effective Tax Rate
11.37%14.14%16.34%17.91%9.08%-